Transpose 3rd Newsletter

This topic contains 3 replies, has 4 voices, and was last updated by  Sabrina Sandner 5 months ago.

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • #772

    Donata Forioso
    Participant

    Dear WP Leaders,
    We kindly ask you to send us a brief text about your WP: what you did so far, what the next steps are and if there are events or news that you would like to share with Transpose members.
    Please, write here in this topic your text, within Friday, April 12th.
    Thank you in advance for your collaboration.
    Donata and WP2 Team

    #776

    Gaia
    Moderator

    Dear WP2, thank you for organizing this 3rd newsletter!

    From us at WP1, we would like to report the following:

    The main goals of WP1 is to monitor the objectives, milestones, deliverables, logistics and time-frame of the TRANSPOSE Project and to coordinate every aspect of it, keeping track of the advancement status of all other WPs and helping them to meet the deadlines.

    WP1 recently organised a meeting in Amsterdam – held on April 3rd – focusing on WP 5, WP6 and commencing work on WP7. We went through each Risk Assessment carried out for Blood risks and reviewed the recommendations made in preparation for the creation of the Donor Selection and Protection Guidelines. Additionally, we evaluated and commented on the first draft of the DHQ prepared by WP6 and discussed how we wish to proceed with WP7 and the teaching of the Donor Selection & Protection Guidelines, Guiding Principles, and the DHQ.

    In the last months, WP1 has been working very closely with WP5 in writing the General Principles as well as developing a survey which will be used to assess the current suitability criteria in order to propose a new DHQ with WP6. Additionally, WP1 has been helping WP7 with their preparations and will be focusing the coming month(s) on the Project Periodic Report.

    #782

    Christina Mikkelsen
    Participant

    Dear WP2, thank you for reminding us:) Please find the news from WP5 below.

    WP5 Newsletter April 2019

    Since the meeting in Copenhagen in September 2018, WP5 members have made risk assessments of current donor eligibility criteria as well as proposed new ones, identified as part of the first WP5 deliverables (described in the first newsletter). The results are now being comprised into a scientific paper and a report.
    Based on this work, the first draft of new guiding principles and guidelines for donor selection was commenced in the early spring 2019. The first draft of guidelines for the selection of donors of whole blood was discussed in a workshop in Amsterdam together with represents from WP3, WP5, WP6 and WP7. Subgroups working with plasma and cells and ART will meet in May to finalize their first draft. The results will be discussed in a teleconference at the end of May in order to complete the work on time by the end of June.
    Alongside this work, WP5 have had two abstracts accepted for the 29th regional congress of the International Society for Blood Transfusion (ISBT) in Basel in June 2019 with the titles “A COMPARISON BETWEEN DIRECTIVE 2004/33/EC AND AN EVALUATION BY EXPERTS IN THE TRANSPOSE PROJECT IDENTIFIES INCONGRUENCE IN WHOLE BLOOD DONOR SELECTION CRITERIA” and LARGE DIFFERENCES IN THE REPORTING OF ADVERSE REACTIONS IN BLOOD AND PLASMA DONATION WITHIN THE EUROPEAN UNION – RESULTS FROM THE TRANSPOSE PROJECT.

    #785

    Sabrina Sandner
    Participant

    Dear WP2, thanks for organizing!:)
    Following the text from WP6:
    State of the art – The first draft of the questionnaire was completed in February. This draft was discussed intensively at the meeting in Amsterdam, which was held at the beginning of April. So far the questionnaire consists of three parts: First donors, repeated donors and deceased donors and all SoHo’s (blood, ART, tissues, plasma, stem cells) are included.
    Upcoming – In the next step, the comments and suggestions from the members of the work package are integrated so that a revised version of the questionnaire can be sent out for further discussion. In addition, several surveys will be carried out to validate the questionnaire in order to submit a validated version by the end of June.

Viewing 4 posts - 1 through 4 (of 4 total)

You must be logged in to reply to this topic.

Login